Alle verbonden artikelen

Targeted therapy for lung cancer.

Auteurs : Meert AP, Cadranel J
Jaar : 2015
Journal : Eur Respir J
Volume : 46
Pagina's : 1239-41

Immune impairments in multiple myeloma bone marrow mesenchymal stromal cells.

Auteurs : André T, Najar M, Stamatopoulos B, Pieters K, Pradier O, Bron D, Meuleman N, Lagneaux L
Jaar : 2015
Journal : Cancer Immunol Immunother
Volume : 64(2)
Pagina's : 213-24

Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab: A Secondary Analysis of the NeoALTTO Trial.

Auteurs : Salgado R, Denkert C, Campbell C, Savas P, Nucifero P, Aura C, de Azambuja E, Eidtmann H, Ellis CE, Baselga J, Piccart-Gebhart M, Michiels S, Bradbury I, Sotiriou C, Loi S
Jaar : 2015
Journal : JAMA Oncol
Volume : 1(4)
Pagina's : 448-54

A multicentre comparison of quantitative (90)Y PET/CT for dosimetric purposes after radioembolization with resin microspheres : The QUEST Phantom Study.(103 collaborators : for Institut Bordet : B. Vanderlinden and P. Flamen)

Auteurs : Willowson KP, Tapner M, Bailey DL, + collaborators (among others :, Flamen P, Vanderlinden B
Jaar : 2015
Journal : Eur J Nucl Med Mol Imaging
Volume : 42
Pagina's : 1202-22

Colorectal cancer: ten years of illusion of progress but advances are on the horizon].

Auteurs : Shaza L, Charette N, Hendlisz A
Jaar : 2015
Journal : Rev Med Brux
Volume : 36
Pagina's : 263-6

Prognosis of neutropenic patients admitted to the intensive care unit.

Auteurs : Mokart D, Darmon M, Resche-Rigon M, Lemiale V, Pène F, Mayaux J, Rabbat A, Kouatchet A, Vincent F, Nyunga M, Bruneel F, Lebert C, Perez P, Renault A, Hamidfar R, Jourdain M, Meert AP, Benoit D, Chevret S, Azoulay E
Jaar : 2015
Journal : Intensive Care Med
Volume : 41(2)
Pagina's : 296-303

Optimal adjuvant treatment for patients with HER2-positive breast cancer in 2015.

Auteurs : Zardavas D, Fouad TM, Piccart-Gebhart M
Jaar : 2015
Journal : Breast
Volume : 24 Suppl 2
Pagina's : S143-8

Towards tuberculosis elimination: an action framework for low-incidence countries.

Auteurs : Lönnroth K, Migliori GB, Abubakar I, + collaborators (among others :, Sculier JP, Raviglione MC
Jaar : 2015
Journal : Eur. Respir. J.
Volume : 45(4)
Pagina's : 928-52

ESR/ERS white paper on lung cancer screening.

Auteurs : Kauczor HU, Bonomo L, Gaga M, Nackaerts K, Peled N, Prokop M, Remy-Jardin M, von Stackelberg O, Sculier JP
Jaar : 2015
Journal : Eur. Respir. J.
Volume : 46(1)
Pagina's : 28-39

Health impacts of anthropogenic biomass burning in the developed world.

Auteurs : Sigsgaard T, Forsberg B, Annesi-Maesano I, Blomberg A, Bølling A, Boman C, Bønløkke J, Brauer M, Bruce N, Héroux ME, Hirvonen MR, Kelly F, Künzli N, Lundbäck B, Moshammer H, Noonan C, Pagels J, Sallsten G, Sculier JP, Brunekreef B
Jaar : 2015
Journal : Eur Respir J
Volume : 46
Pagina's : 1577-88

Myelofibrosis patients in Belgium: disease characteristics.

Auteurs : Devos T, Zachée P, Bron D, Noens L, Droogenbroeck JV, Mineur P, Beguin Y, Berneman Z, Benghiat FS, Kentos A, Chatelain C, Demuynck H, Lemmens J, Eygen KV, Theunissen K, Trullemans F, Pierre P, Pluymers W, Knoops L
Jaar : 2015
Journal : Acta Clin Belg
Volume : 70(2)
Pagina's : 105-11

Long-term analysis of oncological outcomes after laparoscopic radical cystectomy in Europe: results from a multicentre study by the European Association of Urology (EAU) section of Uro-technology.

Auteurs : Albisinni S, Rassweiler J, Abbou C, Cathelineau X, Chlosta P, Fossion L, Gaboardi F, Rimington P, Salomon L, Sanchez-Salas R, Stolzenburg J, Teber D, Van Velthoven R
Jaar : 2015
Journal : BJU Int
Volume : 115(6)
Pagina's : 937-45

Isolation and Characterization of Human Mesenchymal Stromal Cell Subpopulations: Comparison of Bone Marrow and Adipose Tissue.

Auteurs : Busser H, Najar M, Raicevic G, Pieters K, Velez Pombo R, Philippart P, Meuleman N, Bron D, Lagneaux L
Jaar : 2015
Journal : Stem Cells Dev.
Volume : 24(18)
Pagina's : 2142-57

RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancy.

Auteurs : Azim HA, Peccatori FA, Brohée S, Branstetter D, Loi S, Viale G, Piccart-Gebhart M, Dougall WC, Pruneri G, Sotiriou C
Jaar : 2015
Journal : Breast Cancer Res
Volume : 17
Pagina's : 24

Circulating Tumor Cells and Circulating Tumor DNA: Challenges and Opportunities on the Path to Clinical Utility.

Auteurs : Ignatiadis M, Lee M, Jeffrey SS
Jaar : 2015
Journal : Clin Cancer Res
Volume : 21
Pagina's : 4786-800

Intraperitoneal follicular dendritic cell sarcoma: role of chemotherapy and bone marrow allotransplantation in locally advanced disease?

Auteurs : Liberale G, Keriakos K, Azerad M, de Saint-Aubain de Somerhausen N, El Nakadi I
Jaar : 2015
Journal : Clin Med Insights Oncol
Volume : 9
Pagina's : 9-13

Evaluation of a new standardized enzymatic isolation protocol for human umbilical cord-derived stem cells.

Auteurs : Buyl K, Vanhaecke T, Desmae T, Lagneaux L, Rogiers V, Najar M, De Kock J
Jaar : 2015
Journal : Toxicol In Vitro
Volume : 29(6)
Pagina's : 1254-62.

Pregnancy following breast cancer using assisted reproduction and its effect on long-term outcome.

Auteurs : Goldrat O, Kroman N, Peccatori FA, Cordoba O, Pistilli B, Lidegaard O, Demeestere I, Azim HA
Jaar : 2015
Journal : Eur. J. Cancer
Volume : 51(12)
Pagina's : 1490-6

Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy.

Auteurs : Strasser-Weippl K, Horick N, Smith IE, O Shaughnessy J, Ejlertsen B, Boyle F, Buzdar AU, Fumoleau P, Gradishar W, Martin M, Moy B, Piccart-Gebhart M, Pritchard KI, Lindquist D, Rappold E, Finkelstein DM, Goss PE
Jaar : 2015
Journal : Breast Cancer Res
Volume : 17(1)
Pagina's : 56

Evaluation of the optimal combinations of modulation factor and pitch for Helical TomoTherapy plans made with TomoEdge using Pareto optimal fronts.

Auteurs : De Kerf G, Van Gestel D, Mommaerts L, Van den Weyngaert D, Verellen D
Jaar : 2015
Journal : Radiat Oncol
Volume : 10
Pagina's : 191